NO951433L - Kjemiske forbindelser - Google Patents
Kjemiske forbindelserInfo
- Publication number
- NO951433L NO951433L NO951433A NO951433A NO951433L NO 951433 L NO951433 L NO 951433L NO 951433 A NO951433 A NO 951433A NO 951433 A NO951433 A NO 951433A NO 951433 L NO951433 L NO 951433L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- alkyl
- hydrogen
- different
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929221761A GB9221761D0 (en) | 1992-10-16 | 1992-10-16 | Chemical compounds |
| PCT/EP1993/002833 WO1994008993A1 (en) | 1992-10-16 | 1993-10-14 | Benzofuran derivatives as 5-ht1-like receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951433D0 NO951433D0 (no) | 1995-04-12 |
| NO951433L true NO951433L (no) | 1995-04-12 |
Family
ID=10723562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951433A NO951433L (no) | 1992-10-16 | 1995-04-12 | Kjemiske forbindelser |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5494910A (sv) |
| EP (1) | EP0664804A1 (sv) |
| JP (1) | JPH06211842A (sv) |
| KR (1) | KR940009179A (sv) |
| CN (1) | CN1092420A (sv) |
| AP (1) | AP425A (sv) |
| AU (1) | AU5333794A (sv) |
| CA (1) | CA2146569A1 (sv) |
| CZ (1) | CZ96895A3 (sv) |
| EC (1) | ECSP941050A (sv) |
| FI (1) | FI951798A (sv) |
| GB (1) | GB9221761D0 (sv) |
| HU (1) | HUT72752A (sv) |
| IL (1) | IL107302A0 (sv) |
| IS (1) | IS4081A (sv) |
| MX (1) | MX9306394A (sv) |
| NO (1) | NO951433L (sv) |
| PE (1) | PE51294A1 (sv) |
| PL (1) | PL308357A1 (sv) |
| RU (1) | RU95110110A (sv) |
| SI (1) | SI9300542A (sv) |
| TW (1) | TW262473B (sv) |
| WO (1) | WO1994008993A1 (sv) |
| ZA (1) | ZA937633B (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407447D0 (en) * | 1994-04-14 | 1994-06-08 | Glaxo Group Ltd | Chemical compounds |
| EP0759918A1 (en) * | 1994-05-19 | 1997-03-05 | MERCK SHARP & DOHME LTD. | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
| GB9610979D0 (en) * | 1996-05-24 | 1996-07-31 | Merck Sharp & Dohme | Therapeutic agents |
| CA2268164A1 (en) * | 1996-10-08 | 1998-04-16 | Yao-Chang Xu | New serotonin 5-ht1f agonists |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| US20030017175A1 (en) * | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
| US20030198669A1 (en) * | 2001-07-05 | 2003-10-23 | R.T. Alamo Ventures I, Llc | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
| ES2751388T3 (es) | 2011-07-22 | 2020-03-31 | Univ Chicago | IGF-1 para su uso en el tratamiento de la jaqueca |
| KR101443041B1 (ko) * | 2013-05-06 | 2014-09-23 | (주)하이레벤 | 태양광 발전설비의 효율향상설비 |
| AU2022328217A1 (en) | 2021-08-12 | 2024-03-14 | Kuleon Llc | Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670105A1 (de) * | 1966-07-08 | 1970-12-10 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
-
1992
- 1992-10-16 GB GB929221761A patent/GB9221761D0/en active Pending
-
1993
- 1993-10-11 IS IS4081A patent/IS4081A/is unknown
- 1993-10-14 KR KR1019930021263A patent/KR940009179A/ko not_active Application Discontinuation
- 1993-10-14 WO PCT/EP1993/002833 patent/WO1994008993A1/en not_active Application Discontinuation
- 1993-10-14 MX MX9306394A patent/MX9306394A/es unknown
- 1993-10-14 PL PL93308357A patent/PL308357A1/xx unknown
- 1993-10-14 CZ CZ95968A patent/CZ96895A3/cs unknown
- 1993-10-14 ZA ZA937633A patent/ZA937633B/xx unknown
- 1993-10-14 CA CA002146569A patent/CA2146569A1/en not_active Abandoned
- 1993-10-14 RU RU95110110/04A patent/RU95110110A/ru unknown
- 1993-10-14 HU HU9501073A patent/HUT72752A/hu unknown
- 1993-10-14 AU AU53337/94A patent/AU5333794A/en not_active Abandoned
- 1993-10-14 EP EP93923463A patent/EP0664804A1/en not_active Withdrawn
- 1993-10-14 US US08/406,981 patent/US5494910A/en not_active Expired - Fee Related
- 1993-10-15 IL IL107302A patent/IL107302A0/xx unknown
- 1993-10-15 AP APAP/P/1993/000581A patent/AP425A/en active
- 1993-10-15 JP JP5258631A patent/JPH06211842A/ja active Pending
- 1993-10-15 SI SI9300542A patent/SI9300542A/sl unknown
- 1993-10-15 CN CN93115016A patent/CN1092420A/zh active Pending
- 1993-11-04 TW TW082108174A patent/TW262473B/zh active
-
1994
- 1994-03-02 EC EC1994001050A patent/ECSP941050A/es unknown
- 1994-04-13 PE PE1994240029A patent/PE51294A1/es not_active Application Discontinuation
-
1995
- 1995-04-12 NO NO951433A patent/NO951433L/no unknown
- 1995-04-13 FI FI951798A patent/FI951798A/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994008993A1 (en) | 1994-04-28 |
| US5494910A (en) | 1996-02-27 |
| KR940009179A (ko) | 1994-05-20 |
| PL308357A1 (en) | 1995-07-24 |
| ECSP941050A (es) | 1994-11-16 |
| TW262473B (sv) | 1995-11-11 |
| IS4081A (is) | 1994-04-17 |
| NO951433D0 (no) | 1995-04-12 |
| FI951798A0 (sv) | 1995-04-13 |
| CZ96895A3 (en) | 1995-12-13 |
| JPH06211842A (ja) | 1994-08-02 |
| SI9300542A (en) | 1994-06-30 |
| AP9300581A0 (en) | 1993-10-31 |
| AU5333794A (en) | 1994-05-09 |
| ZA937633B (en) | 1994-08-01 |
| GB9221761D0 (en) | 1992-12-02 |
| MX9306394A (es) | 1994-05-31 |
| HUT72752A (en) | 1996-05-28 |
| EP0664804A1 (en) | 1995-08-02 |
| HU9501073D0 (en) | 1995-06-28 |
| CN1092420A (zh) | 1994-09-21 |
| IL107302A0 (en) | 1994-01-25 |
| FI951798A (sv) | 1995-04-13 |
| PE51294A1 (es) | 1995-01-06 |
| AP425A (en) | 1995-11-08 |
| RU95110110A (ru) | 1996-12-27 |
| CA2146569A1 (en) | 1994-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO951266L (no) | Imidazol-holdige inhibitorer for farnesyl-protein-transferase | |
| NO20061170L (no) | Piperazinderivater for behandling av HIV-infeksjoner | |
| DK157678C (da) | Analogifremgangsmaade til fremstilling af amider af hydroxyfenylalkylaminoaetanoler eller terapeutisk acceptable salte deraf samt acetofenonderivat til anvendelse som udgangsmateriale ved fremgangsmaaden | |
| NO951433L (no) | Kjemiske forbindelser | |
| HUP0302526A2 (hu) | Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| KR940701264A (ko) | 안과질환에 대한 마크로라이드 화합물의 용도 | |
| MY105402A (en) | 17-beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation. | |
| HUP0401886A2 (hu) | Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| BG104372A (en) | (benzodioxan, benzofuran or benzopyran) derivatives possessing fundus relaxing properties | |
| HUT71804A (en) | 11,21-bisphenyl-19-norpregnane derivatives, pharmaceutical compositions, process for producing them | |
| DE69008142D1 (de) | 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes. | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| GB0117396D0 (en) | Chemical compounds | |
| EP1277744A4 (en) | OXADIAZONE DERIVATIVES WITH ANTIBODY EFFECT | |
| HUP0102031A2 (hu) | Széles spektrumú gombásodásgátló hatású vízoldható azolok, eljárás az előállítására és a vegyületeket tartalmazó gyógyszerkészítmények | |
| NO994659L (no) | Nye pyridinderivater og farmasöytiske preparater inneholdende slike | |
| NO990335L (no) | Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling | |
| NO20045132L (no) | Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer | |
| FI88393C (sv) | Förfarande för framställning av 17-substituerade androsta-1,4-dien-3-o nderivat | |
| IE812976L (en) | 1,2,5-oxadiazole derivatives | |
| NO20003604D0 (no) | Nye tricykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| NO20045540L (no) | Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem | |
| NO180443C (no) | Oktahydronaftalenoksimderivater samt farmasöytiske preparater som omfatter et slikt derivat til inhibering av kolesterolbiosyntese | |
| NO20000424L (no) | Streptograminer, deres fremstilling samt preparater inneholdende forbindelsene | |
| NO982549L (no) | 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav |